
Rare genetic disease FOP creates a second skeleton in the body
In the United States, 45-year-old Holly LaPrade was diagnosed with a rare genetic disease - fibrodysplasia ossificans progressive, in which new bones grow in the muscles, creating a second skeleton.
AI-generated summary
Fibrodysplasia ossificans progressiva (FOP) is a rare disease in which bones form in muscles, tendons and ligaments, affecting one in two million people.
In the United States, a woman was diagnosed with a rare genetic disease in which new bones grow in the muscles. People reports this.
At age 16, Holly LaPrade began to notice that her neck and shoulders were losing mobility and her arms could no longer lift above her head. Doctors, seeing tumors in soft tissues on x-rays, suspected she had lymphoma.
A biopsy revealed that the cause was fibrodysplasia ossificans progressiva (FOP), a condition in which bones form in muscles, tendons and ligaments, gradually creating a second skeleton and literally “locking” the body into bones. The disease affects approximately one in two million people and was long considered incurable.
The American woman is now 45 years old. There was no treatment when she was diagnosed, but now several drugs have been approved and she calls it "incredible progress." She is married, works as a human resources manager, drives a car, travels and goes to concerts.
LaPrade calls the main difficulty of living with such a diagnosis isolation: the disease is so rare that it is difficult for others to understand the daily restrictions.

More than 1,900 children in eastern DRC have lost parents or guardians due to the Ebola epidemic. According to UNICEF, as of September 29, there were 2,076 confirmed cases among children, of which at least 1,162 had died.

Kenya has reported its first case of Ebola fever, and the patient died in a Nairobi hospital. Authorities are searching for 23 passengers and four crew members of the flight.

Kenya's Ministry of Health has confirmed the country's first case of the Bundibugyo strain of Ebola virus in a patient who arrived from DR Congo via Uganda.

The Russian Ministry of Health has registered the drug Elefuza (fusuloparib), developed by Petrovax Pharm with Chinese partners, for the treatment of aggressive forms of breast and ovarian cancer.

Moscow doctors from the Veresaev City Clinical Hospital successfully performed a hip replacement operation on a 67-year-old patient from Austria who suffered from arthrosis. Because the woman had a defibrillator, doctors used a special plasma instrument.

The state guarantee program in Russia includes new research for the early diagnosis of cancer and atherosclerosis, including determination of cholesterol levels in children and tests for cancer, said Health Minister Mikhail Murashko.